ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000272.1|Spore_2 # 615 # 2270 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.731	BGC0000272.1|Spore_2 	615	2270	+	Loose	550	64.3142	Nocardia farcinica rox	27.41	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGAACGAACGAGGCGGGCAGACGGGTCCGCACACCATCAGCGTCCCGGTCCTCATCGTCGGCGGCTCCCTGGTCGGCCTGTCGACCTCGCTGTTCCTGGGACGGCTGGGCGTGCCGNNCATGCTGGTGGAGCGCCACTCAGGCACCTCCATCCACCCGCGAGGCCGTGGCAACAACGTCCGCACGATGGAGCTGTTCCGGGTGGCGGGCGTCGAGAAGGCGATCCAGGACGCGGCCGCCACCCTGGCCGTCAACAAGGGCATCCTCCAGACGCCCACGCTGACCGGTGACGCGGGCGAGTGGCTGTTCAGGGAGATCGACCCGGGGGGCGGCCTGGCCCGCTTCAGCCCCAGCGCCTGGTGCCTGTGCAGCCAGAACGACCTCGAACCGGTCCTGCTCGACCACGCCCGCGGACACGGCGGGGACCTGCGCTTCTCCACCGAGCTGATGTCGTTCAAGGCCGGCGCCACCGGTGTGACCGCCGTGGTCAAGAGCCGCGAGACGGGTGAGCACACCACCATCCGCGCGGACTATCTCGTCGCCGCGGACGGCCCGCGCAGCCCCGTGCGTGAGCAGCTCGGCATCGGTCAGAGCGGTCCCGGCGACCTGTTCCACAACGTCAGCCTCACCTTCCGCTCCCGCCGCCTCGCCGACGTCGTGGGTGAGCGCCACTTCATCGTCTGCTACCTGACGAACCCGGAGGCCGACGGCGCCCTGCTGCCGGTGGACAACCGCGAGAACTGGGTCTTCCACGCCCCCTGGCACCCCGAACACGGCCAGACCCTGGAGGAATTCACGGACGAGTGGTGCGTCGAGCACATCCGCCGGGCGGTCGGGGTCGCCGACCTCGATGTGGAGATCACCGGCAAGGCGCCGTGGCACGCCGCTCAGCGGGTGGCCCGCAGCTACCGGTCCGGACGGGTGTTCCTGGCCGGTGACTCGGCGCACGAGATGTCTCCCACCGGGGCTTCGGTTCCAACACCGGTATCCAGGACGCCCACAACCTCGCCTGGAAACTGGCCGCGGTGCTCGACGGCTGGGCGGGGGAGCGCCTGCTGGACACCTACGACGCCGAGCGCCGTCCCGTGGCCGAGGCCACCAGCGCGCGTGCCGCGGCCCGGTCGGCCGAGCACAGCCATCCCGGATTCGCCGCGCCGGCCGGAGGGGGCGGCGGCCCCCAGCGCGGCATCCTCAACGTGGCCCTCGGGTACCACTACCCGCAGGCGCGCCGTCGTCGGCGCCGATCCCGCGGCCCCCGTGGTCCCCGAGAGCCTCGACCTGACCGGCGGCCCCGGCAGCAGGGCCCCGCACCTGTGGGTNCGTCACGGGGACGAACGCATGTCGACGCTCGACCTCTACGAGCGGTCCCTGGTGCTGCTCAGTGACGCCGCCGAGCCGAACGGATGGCACGAGGCCGCGCTCCGCCTCGCCGACGATCCGGCCCTGCCGCTCAGGTCGTACCGGGTGGGCACCGGGCCTCAGGCCGACCTGGTACCGGAGGACGCCGCCGACTGGGCGGAGCGCCACGGCACGGGGCCCGGGGGCGCCGTGCTCGTCCGGCCCGACGGGTTCGTCGCATGGCGGTCGCCGGGTCCGGACCCGGCCGCCGAGGACACGCTGCGCCAGGTCCTGAGGACCGGGCTGGCCGTCGGCTGA	MNERGGQTGPHTISVPVLIVGGSLVGLSTSLFLGRLGVPXMLVERHSGTSIHPRGRGNNVRTMELFRVAGVEKAIQDAAATLAVNKGILQTPTLTGDAGEWLFREIDPGGGLARFSPSAWCLCSQNDLEPVLLDHARGHGGDLRFSTELMSFKAGATGVTAVVKSRETGEHTTIRADYLVAADGPRSPVREQLGIGQSGPGDLFHNVSLTFRSRRLADVVGERHFIVCYLTNPEADGALLPVDNRENWVFHAPWHPEHGQTLEEFTDEWCVEHIRRAVGVADLDVEITGKAPWHAAQRVARSYRSGRVFLAGDSAHEMSPTGASVPTPVSRTPTTSPGNWPRCSTAGRGSACWTPTTPSAVPWPRPPARVPRPGRPSTAIPDSPRRPEGAAAPSAASSTWPSGTTTRRRAVVGADPAAPVVPESLDLTGGPGSRAPHLWXRHGDERMSTLDLYERSLVLLSDAAEPNGWHEAALRLADDPALPLRSYRVGTGPQADLVPEDAADWAERHGTGPGGAVLVRPDGFVAWRSPGPDPAAEDTLRQVLRTGLAVG	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	116.49	gnl|BL_ORD_ID|4834|hsp_num:0	5821			3	861	rifampin
BGC0000272.1|Spore_3 # 2604 # 3323 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.699	BGC0000272.1|Spore_3 	2604	3323	+	Loose	550	31.5722	RAHN-1	25.0	3006979	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	RAHN beta-lactamase	ATGTCTCCCAGTCCGTGTTCGACGGTTCCCGGCGTCCGCGTCGTCCTTCTGGTCGACGTCCACGACGGGGCCCAGCAGGAGTTCCTCGAGGCTTACGAACAGTTGTGCAACCAGGTCGCGTCCGTCCCCGGGCATGTCAGCGACCAGCTGTGCCAGTCGATCGAGAATCCCTCCCAGTGGCTCATCACGAGTGAGTGGGAGAGCGCCCCGCCGTTCCTCGCCTGGGTCAACAGCGAGGAGCACGTGCGGATGGTGGAGCCGCTGCACAGCTGCGTGCGCGACACGCGGTCGCTGCGCTTCCACGTCGTCCGCGAGACCGGCGGACCGGCGAAGGGCGCCGACCAGGCGGAGCGCCGCCTCCAGACGGCGCCCCGAATCGGTGACGGTGTGATCCGGCACGCGCTCACGTTCACCGTGAAGCCGGGCAGCGAGGAGATCGTGGCCAAGATCCTCGCCGACTACGACTCGCCCGAGCCGAAGGTCGACGACAGCACCCGGCTGTGCCGCACCTCCCTGTTCATGCACGGCAACCGGGTGGTGCGGGCCGTCGAGGTGCGGGGCGACCTGCTGGCCGCGCTGCGCCACGTCGCCCGGCAGCCCGAGGTGCGGGCCGTCGAGGAGGCGATCAATCCCCACCTCGAACAGGACCGGGACCTGGGCGACCCCGAATCCGCCCGGGTCTTCTTCACCAGGGCGCGCTGCCGGCCGTCCACCATGTGA	MSPSPCSTVPGVRVVLLVDVHDGAQQEFLEAYEQLCNQVASVPGHVSDQLCQSIENPSQWLITSEWESAPPFLAWVNSEEHVRMVEPLHSCVRDTRSLRFHVVRETGGPAKGADQAERRLQTAPRIGDGVIRHALTFTVKPGSEEIVAKILADYDSPEPKVDDSTRLCRTSLFMHGNRVVRAVEVRGDLLAALRHVARQPEVRAVEEAINPHLEQDRDLGDPESARVFFTRARCRPSTM	MMKNTLRKTALMAAAVVPMLAFSAASWAQTATKMTSVQQQLTALEKESGGRLGVMLIDTADNSQIAYRADERFAMCSTSKFMAASAILKESEVKKNLLTQHVALKQSDLVNYNPITEKHLNDGMTIGELAAAALQYSDNAAMNKLIEHLGGPHKVTDYARTLGDKTFRLDRTEPTLNTAIPGDDRDTTSPRAMALSLQHATLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGDKTGSGDYGTTNDIAVIWPENKAPLVLVTYFTQPEKDAKSRRDVLASAAKIVTQGY	81.02	gnl|BL_ORD_ID|4566|hsp_num:0	5636			177	411	
BGC0000272.1|Spore_4 # 3390 # 3704 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.705	BGC0000272.1|Spore_4 	3390	3704	+	Loose	700	24.6386	MOX-5	47.62	3002188	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam	antibiotic inactivation	MOX beta-lactamase	ATGCAGCTCGCCGAACTCCTGGCCCATCGGGACGAGACGGCCGCGGACGACCCGCGCAGCCCGGTCCTGCGCAGCACGATCTTCCAGCGCGACGACGTCGTCGTACGGCTGATCGACGTGCACGGCTCGATCGAGGAGGCCGGCCCCGGCCACATCCTCGGTCTGTCCGACTCGGCGCAGGTGACCGAGCTGACGACGCTCCTGGACGACGTCGCGGACATGGACGTGGCCATGTCGAAGGACGGCAGCCTCGCCCGCCTGCTCGAACTGGCGCGCATGGATCTCGTCACCGACCGCCGGTCGCCCGACGCCTGA	MQLAELLAHRDETAADDPRSPVLRSTIFQRDDVVVRLIDVHGSIEEAGPGHILGLSDSAQVTELTTLLDDVADMDVAMSKDGSLARLLELARMDLVTDRRSPDA	MQQRQSILWGALATLMWAGLAHAGDKAATDPLRPVVDASIRPLLKEHRIPGMAVAVLKDGKAHYFNYGVADRERAVGVSEQTLFEIGSVSKTLTATLGAYAVVQGGFELDDKASLFAPWLKGSAFDNITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSRGSHRQYANPSIGLFGYLAASSMKQPFDRLMEQTMLPGLGLYHTYLNVPEQPMGHYAYGYWKEDKPFRVTPAMLAEEPYGIKTSSADLLRFVKANISGVDNAAMQQAIDLTHQGQYAVGEMTQGLGWERYPYPVSEQTLLAGNSPAMIYNANPAAPAPAAAGHPVLFKKTGSTNGFGAYVAFVPAKGIGVVMLANRNYPNEGTLKAGHAILTQLAR	27.15	gnl|BL_ORD_ID|43|hsp_num:0	53			57	120	
BGC0000272.1|Spore_5 # 3773 # 4036 # 1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.682	BGC0000272.1|Spore_5 	3773	4036	+	Loose	500	25.409	CARB-55	42.86	3005589	protein homolog model	n/a	n/a	penam	antibiotic inactivation	CARB beta-lactamase	GTGATCACATCTCGTCCCAACATCGTGAGCCTGAGCGACGTCGAGCCCAACCGCCGCCGAGGCGGTGACCTGCGCGCCATGCTCACTCCGGCCGCGGTGGGCGCCACCAGTGGATTCATGGGCGTGGCGCTCATCGAACCCGGTGACCGAATCGGTGAGCACTACCACCCGTACTCCGAGGAGTTCGTGTACGTGGTGTGCGGGCAGCTCGAGGTGGACCTGGACGGCGAGCCGCACCCGCTCCGGCCCGAGCAGGGCTGCTGA	MITSRPNIVSLSDVEPNRRRGGDLRAMLTPAAVGATSGFMGVALIEPGDRIGEHYHPYSEEFVYVVCGQLEVDLDGEPHPLRPEQGC	MKFLWAFSHLIPSVVFASSSKFQQVEQDVKAIEVSLSARIGVSVYDTQNGEYWDYNGNQRFPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVIEKQVGQAITLDDACFATMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKAIASTLNKFLFGSALSEMNQKKLESWMVNNQVTGNLLRSVLPAGWNIADRSGAGGFGARSITAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGHSIFDVYTSQSR	30.21	gnl|BL_ORD_ID|3370|hsp_num:0	4439			468	552	
BGC0000272.1|Spore_7 # 4212 # 5480 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.712	BGC0000272.1|Spore_7 	4212	5480	+	Loose	700	25.7942	PDC-214	25.35	3006591	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	ATGACCAGGCGAGTGGCGGTCACCGGCATAGGCATCGTCGCTCCCGGGGGCATAGGCGTACCGGCGTTCTGGAACCTCCTGGCGGCCGGGCGCACCGCGACACGGGCCATCACGTTCTTCGACCCGTCCGGTCTGCGGTCGCGGATCGCCGCCGAGTGCGACTTCGACCCCACTGCCCACGGCCTGGACCCGCGGGACGTGGAACGAAGCGACCGCTACATCCAGTTCGCCATGGTCGCGGGCGACGAGGCGGTACGGGACGCCGGTCTCGATCTCGCCGCCGAGGACCCCTGGCGCGTCGGCGTCTCGCTCGGCACCGCGGTCGGCGGCACCACCCGGCTGGAGCACGACTACGTGCTGGTCAGCCACGGCGGGCAGCGCTGGGACGTGGACCACCGGGAAGCGGGCCCCGACCTGCACCGGGCGTTCACGCCCGGCGCCCTCGCCTCGACGGTGGCGGAGCGGTTCGGAGCGCGCGGCCCGGTGCAGACCGTGTCCACGGGCTGCACCTCCGGGCTCGACGCGGTCGGCTACGCCTTCCACACCGTGGAGGAAGGCCGGGCCGACATCTGCATAGCCGGCGCCTCGGACTCGCCGATCTCCCCGATCACCATGGCCTGCTTCGACGCGATCAAGGCCACCTCCCCGAACAACGACGACCCGGCCCACGCCTCGCGTCCCTTCGACGCCGACCGCGACGGATTCGTCATGGGCGAGGGCGGCGCCGTACTCGTCCTGGAGGAGCTCGAACACGCCAGGGGCCCGCGGTGCGCGCGTGTACTGCGAACTCGGCGGCTACGCCACTTCGGCAACGCCTACCACATGACCGGCCTCACCAGCGAGGGCGTGGAGATGGCCCGCGCCATCGACGACGCCCTCGACCACGCGCGGCTCGACCCCACCGCGATCGACTACGTCAACGCGCACGGCTCGGGCACCAAGCAGAACGACCGCCACGAGACCGCAGCGGTCAAGCGGGTCCTGGGACCGCACGCCTACGAAACCCCCATGAGTTCCATCAAGTCGATGGTGGGCCACTCCCTGGGCGCCATCGGAGCGATCGAACTCGTCGCCTGTGTGCTGGCCCTGACGCACCAGGTGGTGCCGCCGACCGCGAACTACGAGACCCCCGACCCCGAGTGCGACCTGGACTACGTCCCCCGCGAGGCGAGGGAGCGCAAGCTCGACAGCGTGCTCTCGGTGGGCAGCGGATTCGGCGGCTTCCAGTCCGCGGTGGTCATGAACCGGCCGAGGGAGACGTCACGATGA	MTRRVAVTGIGIVAPGGIGVPAFWNLLAAGRTATRAITFFDPSGLRSRIAAECDFDPTAHGLDPRDVERSDRYIQFAMVAGDEAVRDAGLDLAAEDPWRVGVSLGTAVGGTTRLEHDYVLVSHGGQRWDVDHREAGPDLHRAFTPGALASTVAERFGARGPVQTVSTGCTSGLDAVGYAFHTVEEGRADICIAGASDSPISPITMACFDAIKATSPNNDDPAHASRPFDADRDGFVMGEGGAVLVLEELEHARGPRCARVLRTRRLRHFGNAYHMTGLTSEGVEMARAIDDALDHARLDPTAIDYVNAHGSGTKQNDRHETAAVKRVLGPHAYETPMSSIKSMVGHSLGAIGAIELVACVLALTHQVVPPTANYETPDPECDLDYVPREARERKLDSVLSVGSGFGGFQSAVVMNRPRETSR	MRDTGFPCLCGIAASTLLFAATSAIAGEAPADRLKTLVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASLHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYTPGSQRLYSNPSIGLFGYLAARSLGQPFERIMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDKPWAQALNATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR	106.30	gnl|BL_ORD_ID|4281|hsp_num:0	5351			747	945	
BGC0000272.1|Spore_8 # 5477 # 6730 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.734	BGC0000272.1|Spore_8 	5477	6730	+	Loose	750	103.605	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	33.54	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGAGCGAACCTCGTCCACAGCGCGTGGCCGTCACGGGTATCGGTGTGGTCGCGCCCAACGGATCCAGTACCGAGACCTTCTGGAAGTCCACCAGGGAGGGCATCAGCGTCCTGGACCGCGTCACCCGGGAGGGCTGTGAGCATCTGCCGCTGCGGGTGGCGGGCCAGGTGCGCGGCTTCGACCCGTCGGCGGCGATCGAGGAGCGCTTCCTGGTCCAGACCGACCGGTTCACGCACTTCGCGATGGCGGCGGCCGACCTCGCGCTCGACGACGCCCGGCTCCCCCGGTCCGTGACCGACGAGGTGCCGTTCTCCGTCGGTGTGGTCACCGCGGCCGGTTCCGGCGGCGGCGAGTTCGGACAGCGCGAGCTCCAGCAGCTGTGGGGCAAGGGCAGTCGCTTCGTCGGTCCGTACCAGTCCATCGCCTGGTTCTATGCCGCCAGCACCGGCCAGATCTCCATCCGCCGCGGTTTCAAGGGCCCCTGCTCGGTCGTCGCCGCCGACGAGGCCGGCGGCCTGGACGCCCTCGCCCACGCGGCACGAGCCGTACGGCGCGGCACCGATGTGATCGTGGCCGGGGCGACCGAGGCGCCGATCGCGCCCTACTCGGTGGTCTGCCAGCTCGGCTACGAGGAACTCAGCACGGTCGACGACCCGACCCGTGCCTACCGCCCGTTCACGTCCGCGGCCTGCGGGTTCGTGCCCGCTGAGGGGGGCGCCATGGTCGTGGTGGAGGCGGAGGGCACAGCCCGGGAGCGGGGCGCGCCCGTGCGGGCCCACCTGGCCGGACACGCGGCGACCTTCACGGGGGCCTCCCGCTGGGAGGAGTCCCGGGAAGGACTCGCCCAGGCCGTCCGGGGTGCTCTGGCGGAGGCCGGCTGCGCCCCCGAGGAGATCGACGTGGTGTTCGCCGACGCCCTCGGCGTACCGGAGGCGGACCGGGCGGAGGCCCTGGCCATCGCCGACGCTCTCGGGGCCCATGGCACCCGGGTGCCCGTCACCGCGCCGAAGACCGGCATCGGCCGGGGCTACTGCGCGGCGCCGCTGATGGACGCCGCGGCGGCGGTGCTGTCGATGGAGCACGGTCTGATCCCGCCCACCCCCAACGTCTTCGACATCTGCCACGACCTCGACCTCGTGACAGGCCGGGCCCGTACCGCCGAGGTACGCACGGCGCTGGTGCTGAGCCGGGGACTCATGGGGTCGAACTCGGCGCTGGTGCTGAGGCACGGCGCCGCCGACGCCTCGTCGTGA	MSEPRPQRVAVTGIGVVAPNGSSTETFWKSTREGISVLDRVTREGCEHLPLRVAGQVRGFDPSAAIEERFLVQTDRFTHFAMAAADLALDDARLPRSVTDEVPFSVGVVTAAGSGGGEFGQRELQQLWGKGSRFVGPYQSIAWFYAASTGQISIRRGFKGPCSVVAADEAGGLDALAHAARAVRRGTDVIVAGATEAPIAPYSVVCQLGYEELSTVDDPTRAYRPFTSAACGFVPAEGGAMVVVEAEGTARERGAPVRAHLAGHAATFTGASRWEESREGLAQAVRGALAEAGCAPEEIDVVFADALGVPEADRAEALAIADALGAHGTRVPVTAPKTGIGRGYCAAPLMDAAAAVLSMEHGLIPPTPNVFDICHDLDLVTGRARTAEVRTALVLSRGLMGSNSALVLRHGAADASS	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	100.24	gnl|BL_ORD_ID|1968|hsp_num:0	1943			312	1239	isoniazid
BGC0000272.1|Spore_9 # 6763 # 7017 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.671	BGC0000272.1|Spore_9 	6763	7017	+	Loose	500	25.7942	OXA-7	33.33	3001402	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAACGACCGCATCTCGGTGGAAGAGCTGTCCGAACTCATGAAGAAGTGCACCGGTGTCACCGTCGCCCCGGAGGAACTCCGCCGCGACGGGACGGCCTTCGAAAGCCTCGGCGTCGACTCGCTGGGCCTGCTGGGCATCGTGGGCGAGCTGGAGAACCGGTACGGCACGCCGATGCCGACCGACGCCGAACGCTCCAAGACGCCCCGGCAGTTCCTCGACCTCGTCAACGGTGCCCTCCTGGCAGGAGCGTGA	MNDRISVEELSELMKKCTGVTVAPEELRRDGTAFESLGVDSLGLLGIVGELENRYGTPMPTDAERSKTPRQFLDLVNGALLAGA	MKTFAAYVITACLSSTALASSITENTFWNKEFSAEAVNGVFVLCKSSSKLACATNNLARASKEYLPASTFKIPNAIIGLETGVIKNEHQIFKWDGKPRAMKQWERDLSLRGAIQVSAVPVFQQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLFLNKLSASKENQLIVKEALVTEAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKGAEVYFFAFNMDIDNENKLPLRKSIPTKIMASEGIIGG	31.58	gnl|BL_ORD_ID|1051|hsp_num:0	1143			528	645	cloxacillin; oxacillin; cefalotin
BGC0000272.1|Spore_10 # 7019 # 7498 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.673	BGC0000272.1|Spore_10 	7019	7498	+	Loose	300	25.0238	dfrA1	52.94	3002854	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGACCGGACACACACAGAACGAGATCACCATCGCCGCGCCGGTGGACCTGGTCTGGGAGGTGACCAACGACCTGGAGAACTGGCCGCAGCTGTTCAGCGAGTACGCCTCCGTCGAGATCCTCTCCCGGGAGGGCCACAGGACGACCTTCCGGCTGACGATGCACCCGGACGAGAACGGCACCGTGTGGAGCTGGGTCTCCGAGCGCGAGCCGGACCGCGACGCGCTCACCGTCAAGGCCCGCCGCGTCGAGACGGGACCCTTCGCCCACATGGACATCCACTGGCGGTACGAGGAGGTCCCGGCCGGCACGCGGATGGTCTGGACGCAGGACTTCGCGATGAAGCCGGACGCGCCGGTCGACGACGCGTGGATGACGGACAACATCAACCGGAACTCCAAGGTGCAGATGGCCCTGATCCGTGAGCGCGTCGAGAAGATCGCCGCGGAGCGCGGTGCGAGTGCCGGTCTGACCGACTGA	MTGHTQNEITIAAPVDLVWEVTNDLENWPQLFSEYASVEILSREGHRTTFRLTMHPDENGTVWSWVSEREPDRDALTVKARRVETGPFAHMDIHWRYEEVPAGTRMVWTQDFAMKPDAPVDDAWMTDNINRNSKVQMALIRERVEKIAAERGASAGLTD	MKLSLMVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYAVVTRSSFTSDNENVVIFPSIKDALTNLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDIEPEGDVYFPEIPSNFRPVFTQDFASNINYSYQIWQKG	101.27	gnl|BL_ORD_ID|1838|hsp_num:0	1992			381	432	trimethoprim
BGC0000272.1|Spore_11 # 7519 # 7851 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.709	BGC0000272.1|Spore_11 	7519	7851	+	Loose	650	23.483	ALG6-1	31.71	3006893	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	ALG6 beta-lactamases	ATGCACCAAGCCCTGATCGTCGCCCGCATGGCCCCGGGGTCGGCGCCCGACATCGCCAAGGTGTTCGAGGAGTCCGACCGGGGGGAGCTGCCGCACCTCGTCGGTGTGACCCGGCGCAGCCTCTTCCAGTTCGGCGATGTGTACCTGCACCTGATCGAGGCCGAGCGCGACCCCGGGCCGGCCATCGCCAAGATCACCGGCCATCCCGAGTTCCGGGACGTCAGCGAGCGCCTGTCCGCGTACGTCAGCGCGTACGACCCCGCGACCTGGCGTTCCCCGAAGGACGCCATGGCGCAGCGCTTCTACCTCTGGGAGCGCGAGCCGGCCGGCTGA	MHQALIVARMAPGSAPDIAKVFEESDRGELPHLVGVTRRSLFQFGDVYLHLIEAERDPGPAIAKITGHPEFRDVSERLSAYVSAYDPATWRSPKDAMAQRFYLWEREPAG	MSHGIPCAPSSRMETQMVSKMAMAAILLLAGPTAAAEVTPTTPIVCSMCEGWNRPQKPFKIYGNTWYVGTNDLSALLVTSPNGHVLLDGALPQSAPLIEANIQALGFKLKDVKLILNSHEHFDHAGGIPALQRASGATVAASIRGAKVLRAGTVGKDDPQFDPVKPFFLAKLEKVREVADGETLTAGDLRITAHYTPGHTPGGTSWTWTSCENGRCLNMVYADSLTPVSSEGFRFSGGNGAPDISSAFQATIDKVAALKCDVMVSNHPGFSQVMEKLAARTDANNTFIDPTGCRKYAAAASKRLANRLATEAKQKAAR	34.59	gnl|BL_ORD_ID|3290|hsp_num:0	4359			789	912	
BGC0000272.1|Spore_12 # 7936 # 8925 # -1 # ID=1_12;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.714	BGC0000272.1|Spore_12 	7936	8925	-	Loose	500	35.8094	chrB	42.86	3001302	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	TGCGCCGCCGCCCTGCGCGCGGCCGCCCGTCTGGGAATCGCCGACGTCCTCGGCGAGGACCCCATGGCCGCGGAGGACATCGCGGCCGCGGTGAAGACCGAACCCGGACCGCTGCGACGGCTCCTGCGAGCCCTGTCCTGCCACGGCGTCTTCACGGAACGCCCGGACGGGACGTTCGCGCACACCGACGTCTCCCGGCTGCTGCGCGAGGACGACCCCCACAGCCTGCGCGCCATCACGCTGTGGTGCACCGAGCCGTGGACCTGGGACGTCTGGCCGAAGCTGGACGAGGCGGTGCGCACCGGCCGCAACGTGGTGGAGGACCTGTACGGCAAGGAGTTCTTCCCCTACCTCAACGAGGACGCCCCGGAGTCGGCGGACGTCTTCAACCGCGCCATGACGACCTCCAGCGTGCAGTCGGCGCAGGACGTCGCCGCGTTCCTCGACCTCACGGGATGCACCTCGGTGGCCGACGTCGGCGGCGGCCAGGGGCACGTCGTGGCGAGCCTGCTCGACAAGTACCCGGACCTGCGCGGGACGNTGCTCGACCTCCCCCGGGTGGTGGAGAACGCCGTCCCGAGACTGCGCACGGGCGGCGACCTCGCGGACCGCGCGCACGTCGTGCCCGGCGACGTCCGGACGGCCGTCCCGGTGAAGGCCGACGTCTACGTGATCAAGAACATCCTGGAGTGGGACGACGAGAGCACCACCCGCACGCTGCGCAACGTCCGCGAGGCCGGCGGCCCCGGGACGCGCGTGGTGGTCATCGAGAACNTCGTCGACGACTCGCCCTCGATGCGGTTCAGCACCGCGATGGACCTGCTGCTGCTCCTCAACGTCGGCGGGGCCAAGCACACCCGGCAGAGCATGGTGGACCGGCTCACCGAGGCCGGCCTGGTCATCGACGACATCAGCCCGGTCAACCCCTATCTGCACGCGTTCGACTGCACATCCCCGGCTGATCCGACCGCTTCCCGGGGGACCCGGTGA	CAAALRAAARLGIADVLGEDPMAAEDIAAAVKTEPGPLRRLLRALSCHGVFTERPDGTFAHTDVSRLLREDDPHSLRAITLWCTEPWTWDVWPKLDEAVRTGRNVVEDLYGKEFFPYLNEDAPESADVFNRAMTTSSVQSAQDVAAFLDLTGCTSVADVGGGQGHVVASLLDKYPDLRGTXLDLPRVVENAVPRLRTGGDLADRAHVVPGDVRTAVPVKADVYVIKNILEWDDESTTRTLRNVREAGGPGTRVVVIENXVDDSPSMRFSTAMDLLLLLNVGGAKHTRQSMVDRLTEAGLVIDDISPVNPYLHAFDCTSPADPTASRGTR	MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA	117.50	gnl|BL_ORD_ID|274|hsp_num:0	305			270	369	tylosin; chalcomycin; mycinamicin
